SCHEMBL595015

SCHEMBL595015

COC(=O)C(C)(O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.64
SRC P12931 1/20 0.53
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
CES1 P23141 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
ELANE P08246 1/20 0.44
NR1H2 P55055 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6684121 1.00 KCNN4 (0.64) KCNN4SRCHDAC3HDAC4HDAC1
SCHEMBL6689010 1.00 KCNN4 (0.64) KCNN4SRCHDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL27493060 0.98 KCNN4 (0.62) KCNN4SRCHDAC3HDAC4HDAC1
SCHEMBL7759944 0.86 SMN1; SMN2 (0.50) KCNN4SRCKMT2AELANEALDH1A1
SCHEMBL4116704 0.85 KCNN4 (0.50) KCNN4SRCHDAC3HDAC4HDAC1
SCHEMBL15165866 0.82 MAPT (0.48) KCNN4SRCHDAC3HDAC4HDAC1
SCHEMBL28121349 0.82 CYP2C19 (0.47) KCNN4SRCHDAC3HDAC4HDAC1
SCHEMBL6698952 0.82 ESR1 (0.46) KCNN4SRCMAPTELANETSHR
SCHEMBL16732028 0.81 KCNN4 (0.67) KCNN4SRCHDAC3HDAC4HDAC1
SCHEMBL728471 0.81 KCNN4 (0.67) KCNN4SRCHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240421372-A1 SPENT SECONDARY BATTERY CATHODE REGENERATION SOLUTION AND CATHODE REGENERATION METHOD USING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2024-12-19 US claimed
CN-115304516-A Compounds with unconventional chromophores, their preparation and use 四川大学 2022-11-08 CN claimed
CN-112592274-B Process for synthesizing methyl p-hydroxyphenylpropionate 江苏极易新材料有限公司 2022-08-09 CN claimed
CN-111303551-B Vinyl chloride resin compound and preparation method thereof BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) 2021-06-22 CN claimed
CN-112592274-A Process for synthesizing methyl p-hydroxyphenylpropionate 江苏极易新材料有限公司 2021-04-02 CN claimed
CN-109134765-B Graft copolymer of polyisobutylene and polyisoprene and preparation method thereof 北京化工大学 2020-11-03 CN claimed
CN-111303551-A Vinyl chloride resin compound and preparation method thereof 北京化工大学 2020-06-19 CN claimed
CN-109134765-A A kind of polyisobutene and the graft copolymer of polyisoprene and preparation method thereof 北京化工大学 2019-01-04 CN claimed
CN-108114508-A Sterile chromatographic resin and its purposes in a manufacturing process 建新公司 2018-06-05 CN claimed
CN-106674002-A Preparation method of hindered phenol antioxidant 天津利安隆新材料股份有限公司 2017-05-17 CN claimed
CN-106068150-A Sterile chromatography resin and use thereof in manufacturing process 建新公司 2016-11-02 CN claimed
WO-2006119283-A2 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J (US) 2006-11-09 WO claimed
US-20060251597-A1 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J 2006-11-09 US claimed
US-20250388565-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2025-12-25 US disclosed
WO-2025132660-A1 METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION L'OREAL (FR) 2025-06-26 WO disclosed
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 EP disclosed
WO-1987004349-A1 PEPTIDE ANALOGS DELLARIA JOSEPH 1987-07-30 WO disclosed
EP-0230266-A2 Functionalized peptidyl aminodiols and -triols ABBOTT LABORATORIES (US) 1987-07-29 EP disclosed
EP-0229667-A2 Peptidylaminodiols ABBOTT LABORATORIES (US) 1987-07-22 EP disclosed
US-4644003-A LOCALIZED ANESTHESIA RESEARCH CORPORATION (US) 1987-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388565-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND METHODS OF USE THEREOF ESRRA, ESRRB, ESR2 KCNN4 3567/4885SRC 1584/4885HDAC3 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.